ADC Therapeutics (ADCT), a commercial-stage oncology-focused biotechnology company, will host a conference call on December 11, 2024, to review preliminary data from its LOTIS-7 Phase 1b open-label clinical trial.
This trial is evaluating the safety and efficacy of the company's lead drug, Zynlonta, in combination with an approved bispecific antibody, i.e. Roche's Glofitamab (COLUMVI) in patients with relapsed or refractory diffuse large B-cell lymphoma (r/r DLBCL).
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.